Evidence map›Paper›PMID 17217536›Full record

ArticleRespiratory research2007

Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study.

Medea Imboden, Sara H Downs, Oliver Senn, Gabor Matyas, Otto Brändli, Erich W Russi, Christian Schindler, Ursula Ackermann-Liebrich, Wolfgang Berger, Nicole M Probst-Hensch and 1 more

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. [COPD: An early disease].Revue de pneumologie clinique · 2016
    Review
  9. Article
  10. Variants of asthma and chronic obstructive pulmonary disease genes and lung function decline in aging.The journals of gerontology. Series A, Biological sciences and medical sciences · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Updates on the COPD gene list.International journal of chronic obstructive pulmonary disease · 2012
    Review
  16. Article
  17. Article
  18. Review
  19. Genetics and genomics of chronic obstructive pulmonary disease.Proceedings of the American Thoracic Society · 2009
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Medea ImbodenInstitutes of Social and Preventive Medicine & Surgical Pathology, Molecular Epidemiology/Cancer Registry, University of Zurich & University Hospital Zurich, Switzerland. imboden@medgen.unizh.ch <imboden@medgen.unizh.ch>
Sara H Downs
Oliver Senn
Gabor Matyas
Otto Brändli
Erich W Russi
Christian Schindler
Ursula Ackermann-Liebrich
Wolfgang Berger
Nicole M Probst-Hensch
SAPALDIA Team
University of Zurich · CHInstitute of Social and Preventive Medicine · CHUniversity of Basel · CHUniversity Hospital of Zurich · CHZürcher RehaZentrum Davos · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding the environmental and genetic risk factors of accelerated lung function decline in the general population is a first step in a prevention strategy against the worldwide increasing respiratory pathology of chronic obstructive pulmonary disease (COPD). Deficiency in antioxidative and detoxifying Glutathione S-transferase (GST) gene has been associated with poorer lung function in children, smokers and patients with respiratory diseases. In the present study, we assessed whether low activity variants in GST genes are also associated with accelerated lung function decline in the general adult population.

methodsWe examined with multiple regression analysis the association of polymorphisms in GSTM1, GSTT1 and GSTP1 genes with annual decline in FEV1, FVC, and FEF25-75 during 11 years of follow-up in 4686 subjects of the prospective SAPALDIA cohort representative of the Swiss general population. Effect modification by smoking, gender, bronchial hyperresponisveness and age was studied.

resultsThe associations of GST genotypes with FEV1, FVC, and FEF25-75 were comparable in direction, but most consistent for FEV1. GSTT1 homozygous gene deletion alone or in combination with GSTM1 homozygous gene deletion was associated with excess decline in FEV1 in men, but not women, irrespective of smoking status. The additional mean annual decline in FEV1 in men with GSTT1 and concurrent GSTM1 gene deletion was -8.3 ml/yr (95% confidence interval: -12.6 to -3.9) relative to men without these gene deletions. The GSTT1 effect on the FEV1 decline comparable to the observed difference in FEV1 decline between never and persistent smoking men. Effect modification by gender was statistically significant.

conclusionOur results suggest that genetic GSTT1 deficiency is a prevalent and strong determinant of accelerated lung function decline in the male general population.

Indexed as

AdultCohort StudiesFemaleGenetic Predisposition to DiseaseGenetic TestingGenotypeGlutathione TransferaseHumansMalePolymorphism, Single NucleotidePrevalencePulmonary Disease, Chronic ObstructiveRespiratory Function TestsRisk AssessmentRisk FactorsSex DistributionGlutathione Transferase

Identifiers

PMID17217536
PMCPMC1781067
OpenAlexW1550247972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.